Navigation Links
CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women
Date:10/21/2009

PHILADELPHIA, Oct. 21 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) recommended that CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] be given to girls and young women to protect against cervical pre-cancers and cervical cancer caused by oncogenic HPV 16 and 18. The ACIP specifically recommended CERVARIX for routine administration among 11 and 12 year old girls. In addition, the recommendation includes a catch up for girls and young women who have not previously been vaccinated, which for the approved age range for CERVARIX includes 13-25 year old girls and young women.

On October 16, 2009, the Food and Drug Administration (FDA) approved CERVARIX for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).

"It's estimated that this year, ten women will die every day from cervical cancer in the U.S.," said Barbara Howe, M.D., Vice President and Director, North American Vaccine Development, GlaxoSmithKline. "The ACIP recommendation for CERVARIX underscores how important it is for girls and young women to be vaccinated to help reduce the burden of this devastating cancer."

Additionally, the ACIP unanimously recommended to provide funding for CERVARIX from the Vaccines for Children (VFC) program. The federally funded program provides vaccines at no cost to children up through 18 years of age who might not otherwise be vaccinated because of inability to pay. Children who are eligible for VFC vaccines are entitled to receive pediatric vaccines that are recommended by the ACIP.

CERVARIX is expected to be commercially
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman
2. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
3. Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia
6. FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
7. Top Medical Research Centers Form Velos Advisory Group for Service-Oriented Architecture
8. Advanced Life Sciences Announces Outcome of FDAs Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)
9. FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmabs ARZERRA(TM) (ofatumumab)
10. FDA Advisory Panel Recommends Approval of the SEDASYS(R) System
11. Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... Feb. 8 Transgenomic, Inc. ... has completed a preliminary study with a leading ... licensed COLD-PCR technology to detect colorectal tumor-associated KRAS ... These were detected in plasma samples in which ... by standard DNA analysis methodologies such as Sanger ...
(Date:2/8/2010)... Feb. 8 Sagent Pharmaceuticals, Inc., ... that it has received FDA approval of labetalol ... severe hypertension.  The product will be available in ... mL and 200 mg per 40 mL, multi-dose ... than 70 million Americans have hypertension, or high ...
(Date:2/8/2010)... Feb. 8 Connectyx Technologies ... an advertising contract with SkyMall Inc. SkyMall produces ... in major airlines seat pockets. SkyMall has an ... advertisement featuring the MedFlash ® Personal Health ... table of contents in the front section of ...
Breaking Medicine Technology:Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 2Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 3Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 4Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP 2Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP 3Connectyx Announces MedFlash(R) Advertising Contract with SkyMall Inc. 2Connectyx Announces MedFlash(R) Advertising Contract with SkyMall Inc. 3The ALS Association Cares for Those Who Care the Most in New Campaign 60077 1The ALS Association Cares for Those Who Care the Most in New Campaign 60077 2The ALS Association Cares for Those Who Care the Most in New Campaign 60077 3The ALS Association Cares for Those Who Care the Most in New Campaign 60077 4The ALS Association Cares for Those Who Care the Most in New Campaign 60077 5The ALS Association Cares for Those Who Care the Most in New Campaign 60077 6CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 1CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 2CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 3Uruguay 231 for Prosperity in South America 3B Venezuela and Bolivia the Worst in the Region Finds Legatum Prosperity Index 60071 1Uruguay 231 for Prosperity in South America 3B Venezuela and Bolivia the Worst in the Region Finds Legatum Prosperity Index 60071 2Uruguay 231 for Prosperity in South America 3B Venezuela and Bolivia the Worst in the Region Finds Legatum Prosperity Index 60071 3Uruguay 231 for Prosperity in South America 3B Venezuela and Bolivia the Worst in the Region Finds Legatum Prosperity Index 60071 4Uruguay 231 for Prosperity in South America 3B Venezuela and Bolivia the Worst in the Region Finds Legatum Prosperity Index 60071 5Uruguay 231 for Prosperity in South America 3B Venezuela and Bolivia the Worst in the Region Finds Legatum Prosperity Index 60071 6
... fatty acid synthase,inhibitor (FASi) compounds, led by FAS031, ... line tested, in both orthotopic,and flank models: 4 ... two,ovarian; breast; and, colon. In many cases the ... in extensive preclinical studies to,be remarkably safe and ...
... that the U.S. Food and Drug Administration ... combination with cisplatin,and 5-fluorouracil for induction therapy ... head and neck (SCCHN) before patients undergo,chemoradiotherapy ... approval on the results of the phase ...
Other Medicine Technology:FASgen Announces Significant Milestone in Its Cancer Drug Development Program 2Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 2Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 3Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 4
(Date:2/9/2010)... research group of Dr. Franois Robert, a researcher at ... collaboration with the team of Dr. Daniel Durocher (Samuel ... technical breakthrough: they mapped all the fragile sites of ... . The method used by the researchers can be ... today in the scientific journal Nature Structural and ...
(Date:2/9/2010)... launched the nation,s first comprehensive research and training ... FBI has called "the crime of the 21st ... to food additives to auto parts- accounts for ... and has a major impact on health and ... Terrorist and other organized crime groups use proceeds ...
(Date:2/9/2010)... may be more effective in persuading young women to ... same issue, according to a new study. , Researchers ... about a teen pregnancy felt more vulnerable two weeks ... support for using birth control. , However, those who ... teen pregnancies were unmoved, and had no change in ...
(Date:2/9/2010)... Rockville, MD -- The first results from a ... Sub-Saharan African countries reveal that a high percentage ... substandard quality and thus may contribute to the ... , the most virulent form of malaria. The ... of Medicines (PQM) Program, a USAID-funded program implemented ...
(Date:2/9/2010)... YORK , Feb. 9 The ... Glover Blackwell : ,, "Reversing the childhood obesity epidemic ... Michelle Obama demonstrated today. ,, "As ... attend schools loaded with chips and soda -- and ... children, however, that bleak food landscape extends far beyond ...
Breaking Medicine News(10 mins):Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3
... of Bone and Mineral Research study by Indiana University-Purdue University ... fractures later in life. The study is now available in ... in a print edition in 2007. ,'Our ... of fractures later in life, and the old exercise adage ...
... to a International Labor Organization (ILO) report issued on Dec ... unable to work partially or fully due to// HIV and ... ILO added that the virus had a crippling effect on ... the virus has among children has threatened the future working ...
... Allergo Sorbent Test’ (RAST) machine, has been designed at ... the source allergen. ,An allergy is regarded ... it perceives as unsuitable. Hay fever, migraine, asthma, allergic ... the common allergic responses. ,At a press ...
... Scientists at Kings College, London have developed a new drug ... concept on which the drug is based on is that ... is prevented, thus sperms are not propelled out of the ... the control of schizophrenia and blood pressure, to which researchers ...
... implanted devices in their hearts face risks. The devices called ... allow an easy passage of// blood. It is inserted into ... that are coated with drugs are more liable to suffer ... times greater when compared to patients who use stents that ...
... with support from National Institute of Health and ... (ICMR), conducts// Sentinel Surveillance every year among high-risk ... the results of HIV prevalence in different population ... prevalence states where HIV prevalence among antenatal mothers ...
Other Medicine News:Health News:Exercise In Childhood Provides Lifelong Benefits 2Health News:ILO Reports On The Crippling Effects Of HIV On The Workforce 2Health News:Using Heart Stents Tends to Form More Clots 2
The second-generation Dade Behring Acute Care Troponin I (cTnI) method is the first FDA cleared high sensitivity cTnI assay with the low-end precision necessary to meet the ESC/ACC guidelines (CV <10...
... high-throughput immunoassay system built around the many ... the important addition of Logic Driven Incubation ... designed for optimal performance with the fastest ... assays such as the cardiac biomarkers and ...
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
IRMA kit for detection of the cardiac marker Myoglobin...
Medicine Products: